| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $313.9M | — | +22.4% |
| R&D Expense | $18.4M | — | +65.8% |
| SG&A Expense | $30.7M | — | +31.9% |
| Operating Income | $80.5M | — | +23.4% |
| Pre-tax Income | $59.8M | — | +29.2% |
| Income Tax | $16.5M | — | -3.0% |
| Net Income | $43.3M | — | +47.9% |
| EPS (Basic) | $0.23 | — | +35.3% |
| EPS (Diluted) | $0.22 | — | +37.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.3M | -44.0% | -84.7% |
| Accounts Receivable | $172.5M | -2.5% | +17.2% |
| Current Assets | $386.6M | +25.4% | -12.2% |
| Total Assets | $5.84B | +0.9% | +26.4% |
| Current Liabilities | $220.0M | +0.9% | +55.7% |
| Long-term Debt | $1.46B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $84.9M | — | +32.2% |
| Investing Cash Flow | -$112.5M | — | -276.7% |
| Financing Cash Flow | $13.5M | — | +25.3% |
| +19.5% |
| Total Liabilities | $1.90B | -0.2% | +27.3% |
| Stockholders' Equity | $3.94B | +1.5% | +26.0% |